Pictet Asset Management Holding SA Sells 17,412 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pictet Asset Management Holding SA cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 989,600 shares of the medical equipment provider's stock after selling 17,412 shares during the quarter. Pictet Asset Management Holding SA owned 0.28% of Intuitive Surgical worth $516,532,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Norges Bank purchased a new position in Intuitive Surgical in the 4th quarter worth $2,401,493,000. Proficio Capital Partners LLC grew its stake in shares of Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after buying an additional 948,902 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $313,769,000. Wilmington Savings Fund Society FSB lifted its stake in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after acquiring an additional 552,058 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after acquiring an additional 360,591 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Piper Sandler reiterated an "overweight" rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $611.86.

Intuitive Surgical Stock Down 0.3 %

Shares of Intuitive Surgical stock traded down $1.40 on Tuesday, reaching $493.87. The company's stock had a trading volume of 634,248 shares, compared to its average volume of 1,526,696. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm's fifty day simple moving average is $554.33 and its two-hundred day simple moving average is $532.98. The company has a market capitalization of $175.91 billion, a price-to-earnings ratio of 77.31, a P/E/G ratio of 5.85 and a beta of 1.43.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last ninety days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.